Chapter 11 emergence target
Company: Core Scientific
What the later record shows
Delivered late · happened January 23, 2024
A plan exhibit filed on 2024-01-16 still describes distributions as occurring on a future Effective Date. A 2025 filing references a Warrant Agreement and a CVR Agreement both dated January 23, 2024, which are plan-issued instruments, so emergence appears to have occurred after Q4 2023. No passage explicitly states the emergence date.
“on the later of (as applicable) (i) the Effective Date or as soon as reasonably practicable thereafter”
2024-01-16 · core-scientific 8-K exhibit (d598371dex991.htm) View cached copy (2026-11-14)Live source ↗
“refers to the Contingent Value Rights Agreement, dated as of January 23, 2024, by and between Core Scientific and Computershare Inc.”
2025-09-25 · Core Scientific DEFM14A filed 2025-09-26 View cached copy (2026-08-31)Live source ↗
“refers to the Warrant Agreement, dated as of January 23, 2024, by and between Core Scientific and Computershare Inc.”
2025-09-25 · Core Scientific DEFM14A filed 2025-09-26 View cached copy (2026-08-31)Live source ↗
Checked November 20, 2026 against filings, releases and reporting published after the claim was made. Quotes are verbatim from the linked documents.
The claim, verbatim
Core Scientific is continuing through its Chapter 11 reorganization and aims to emerge in the fourth quarter of 2023.
Source (primary)
core-scientific 8-K exhibit (d509828dex993.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-11-20)Live source ↗
Quote: “The Company continues to work through the Chapter 11 reorganization process and aims to emerge in the fourth quarter.”
How we checked this
Checked on November 21, 2026. The cited source supports every part of this claim.
The release, dated September 7, 2023, says the company continues through Chapter 11 and aims to emerge in the fourth quarter. The release date places that quarter in 2023.
Confirmed in the source:
- Core Scientific is continuing to work through its Chapter 11 reorganization process
- Core Scientific aims to emerge from Chapter 11 in the fourth quarter, which in a release dated September 7, 2023 refers to the fourth quarter of 2023
What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1839341/000119312523231176/d509828dex993.htm) in full (9,843 characters, retrieved November 20, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms core-scientific 8-K exhibit (d509828dex993.htm)
Quote: “The Company continues to work through the Chapter 11 reorganization process and aims to emerge in the fourth quarter.”
confirms Core Scientific DEFM14A filed 2025-09-26
Quote: “refers to the Contingent Value Rights Agreement, dated as of January 23, 2024, by and between Core Scientific and Computershare Inc.”
confirms core-scientific 8-K exhibit (d598371dex991.htm)
Quote: “on the later of (as applicable) (i) the Effective Date or as soon as reasonably practicable thereafter”